Xenetic Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.85

-0.10 (-3.23%)

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,181.8% upside

Low Target $23.38

Average Target $36.53

High Target $47.42

Current Price $2.85

Current
$2.85

Target
$36.53

$23.38 $36.53 avg $47.42

Scenario Analysis

Bear Case

$23.38

720.4%

Low target

Base Case

$36.53

+1,181.8%

Avg target

Bull Case

$47.42

+1,563.9%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$13.93

-79.5% from high

52-Week Low

$1.90

+50.0% from low

Target vs 52W High

$36.53

+162.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.1%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-12.3%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.5%